These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 14635227)

  • 21. MAP kinase and beta-catenin signaling in HGF induced RPE migration.
    Liou GI; Matragoon S; Samuel S; Behzadian MA; Tsai NT; Gu X; Roon P; Hunt DM; Hunt RC; Caldwell RB; Marcus DM
    Mol Vis; 2002 Dec; 8():483-93. PubMed ID: 12500177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
    MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
    Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of scatter factor/hepatocyte growth factor is regionally correlated with the initiation of sperm motility in murine male genital tract: is scatter factor/hepatocyte growth factor involved in initiation of sperm motility?
    Naz RK; Joseph A; Lee Y; Ahmad K; Bhargava MM
    Mol Reprod Dev; 1994 Aug; 38(4):431-9. PubMed ID: 7980952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
    Montesano R; Soriano JV; Malinda KM; Ponce ML; Bafico A; Kleinman HK; Bottaro DP; Aaronson SA
    Cell Growth Differ; 1998 May; 9(5):355-65. PubMed ID: 9607557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
    Jeffers M; Rong S; Anver M; Vande Woude GF
    Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
    Zhang KX; Ward KR; Schrader JW
    Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A; Götze T; Korc M
    Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
    Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
    EXS; 1993; 65():311-28. PubMed ID: 8380739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential requirement of Grb2 and PI3-kinase in HGF/SF-induced cell motility and tubulogenesis.
    Royal I; Fournier TM; Park M
    J Cell Physiol; 1997 Nov; 173(2):196-201. PubMed ID: 9365521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis, and signal transduction of primary rat hepatocytes.
    Stolz DB; Michalopoulos GK
    J Cell Biochem; 1994 Aug; 55(4):445-64. PubMed ID: 7962176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway.
    Cho MK; Kim SG
    Hepatology; 2003 Mar; 37(3):686-95. PubMed ID: 12601366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells.
    Gherardi E; Sharpe M; Lane K; Sirulnik A; Stoker M
    Symp Soc Exp Biol; 1993; 47():163-81. PubMed ID: 8165564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium.
    Nusrat A; Parkos CA; Bacarra AE; Godowski PJ; Delp-Archer C; Rosen EM; Madara JL
    J Clin Invest; 1994 May; 93(5):2056-65. PubMed ID: 8182137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3'-kinase and mitogen-activated protein kinase.
    Jin K; Mao XO; Del Rio Guerra G; Jin L; Greenberg DA
    J Neurosci Res; 2005 Aug; 81(4):497-505. PubMed ID: 15952178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor induces delayed STAT3 phosphorylation through interleukin-6 expression.
    Lee BS; Park M; Cha HY; Lee JH
    Cell Signal; 2009 Mar; 21(3):419-27. PubMed ID: 19071214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the met/hepatocyte growth factor/scatter factor receptor and its ligand during differentiation of murine P19 embryonal carcinoma cells.
    Yang XM; Park M
    Dev Biol; 1993 Jun; 157(2):308-20. PubMed ID: 8388815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
    Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.